Moreover, government programs have led to an increase in access to contraceptives that help prevent unwanted pregnancies in teenagers. The section below outlines key market factors such as research and development and trends shaping the women’s contraceptive health market. It highlights recent product launches, regulatory approvals, public health initiatives, and technological innovations that are expanding contraceptive choices, improving accessibility, and driving market growth in the U.S.
U.S. Contraceptive Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. contraceptive market report based on product and region.Product Outlook (Revenue, USD Billion, 2021-2033)
- Pills
- Intrauterine Devices (IUD)
- Hormonal IUD
- Nonhormonal IUD
- Condoms
- Male Condoms
- Female Condoms
- Vaginal Ring
- Subdermal Implants
- Injectable
- Others
Region Outlook (Revenue, USD Billion, 2021-2033)
- West
- Southeast
- Southwest
- Northeast
- Midwest
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Church & Dwight Co., Inc.
- Reckitt Benckiser Group Plc
- Organon Group of Companies
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cooper Companies, Inc.
- Mayer Laboratories Inc
- Agile Therapeutics
- Mayne Pharma Group Limited.
- Bayer AG
- Afaxys, Inc.
- AbbVie
- Gedeon Richter
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | March 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 8.4 Billion |
| Forecasted Market Value ( USD | $ 12.4 Billion |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | United States |
| No. of Companies Mentioned | 13 |


